216 related articles for article (PubMed ID: 28427085)
1. Tumour invasiveness, the local and systemic environment and the basis of staging systems in colorectal cancer.
Park JH; van Wyk H; Roxburgh CSD; Horgan PG; Edwards J; McMillan DC
Br J Cancer; 2017 May; 116(11):1444-1450. PubMed ID: 28427085
[TBL] [Abstract][Full Text] [Related]
2. The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer.
Patel M; McSorley ST; Park JH; Roxburgh CSD; Edwards J; Horgan PG; McMillan DC
Br J Cancer; 2018 Mar; 118(5):705-712. PubMed ID: 29337962
[TBL] [Abstract][Full Text] [Related]
3. The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
van Wyk HC; Park JH; Edwards J; Horgan PG; McMillan DC; Going JJ
Br J Cancer; 2016 Jul; 115(2):156-63. PubMed ID: 27299960
[TBL] [Abstract][Full Text] [Related]
4. The Relationship Between Tumor Budding, Tumor Microenvironment, and Survival in Patients with Primary Operable Colorectal Cancer.
van Wyk HC; Roseweir A; Alexander P; Park JH; Horgan PG; McMillan DC; Edwards J
Ann Surg Oncol; 2019 Dec; 26(13):4397-4404. PubMed ID: 31605345
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores.
Dolan RD; McSorley ST; Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
Br J Cancer; 2018 Jul; 119(1):40-51. PubMed ID: 29789606
[TBL] [Abstract][Full Text] [Related]
6. The relationship between the local and systemic inflammatory responses and survival in patients undergoing curative surgery for colon and rectal cancers.
Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
J Gastrointest Surg; 2009 Nov; 13(11):2011-8; discussion 2018-9. PubMed ID: 19768511
[TBL] [Abstract][Full Text] [Related]
7. The relationship between tumour site, clinicopathological characteristics and cancer-specific survival in patients undergoing surgery for colorectal cancer.
Powell AG; Wallace R; McKee RF; Anderson JH; Going JJ; Edwards J; Horgan PG
Colorectal Dis; 2012 Dec; 14(12):1493-9. PubMed ID: 22507826
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer.
Richards CH; Roxburgh CS; Anderson JH; McKee RF; Foulis AK; Horgan PG; McMillan DC
Br J Surg; 2012 Feb; 99(2):287-94. PubMed ID: 22086662
[TBL] [Abstract][Full Text] [Related]
9. The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
Park JH; Richards CH; McMillan DC; Horgan PG; Roxburgh CSD
Ann Oncol; 2014 Mar; 25(3):644-651. PubMed ID: 24458470
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a tumor microenvironment-based prognostic score in primary operable colorectal cancer.
Park JH; McMillan DC; Powell AG; Richards CH; Horgan PG; Edwards J; Roxburgh CS
Clin Cancer Res; 2015 Feb; 21(4):882-8. PubMed ID: 25473000
[TBL] [Abstract][Full Text] [Related]
11. Histologic prognostic markers in stage IIA colorectal cancer: a comparative study.
Barresi V; Reggiani Bonetti L; Ieni A; Branca G; Tuccari G
Scand J Gastroenterol; 2016 Mar; 51(3):314-20. PubMed ID: 26554618
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
[TBL] [Abstract][Full Text] [Related]
13. Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer.
Hatthakarnkul P; Pennel K; Alexander P; van Wyk H; Roseweir A; Inthagard J; Hay J; Andersen D; Maka N; Park J; Roxburgh C; Thuwajit C; McMillan D; Edwards J
J Pathol Clin Res; 2024 May; 10(3):e12374. PubMed ID: 38650367
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the prognostic value of measures of the tumor inflammatory cell infiltrate and tumor-associated stroma in patients with primary operable colorectal cancer.
Park JH; McMillan DC; Edwards J; Horgan PG; Roxburgh CS
Oncoimmunology; 2016 Mar; 5(3):e1098801. PubMed ID: 27141369
[TBL] [Abstract][Full Text] [Related]
15. The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer.
Gujam FJ; McMillan DC; Mohammed ZM; Edwards J; Going JJ
Br J Cancer; 2015 Sep; 113(7):1066-74. PubMed ID: 26263482
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of combined measures of the systemic inflammatory response in patients with colon cancer: an analysis of 1700 patients.
Golder AM; McMillan DC; Park JH; Mansouri D; Horgan PG; Roxburgh CS
Br J Cancer; 2021 May; 124(11):1828-1835. PubMed ID: 33762720
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of the role of inflammation in renal cancer.
Qayyum T; McArdle PA; Lamb GW; Going JJ; Orange C; Seywright M; Horgan PG; Oades G; Aitchison MA; Edwards J
Urol Int; 2012; 88(3):277-81. PubMed ID: 22377628
[TBL] [Abstract][Full Text] [Related]
18. The modified Glasgow prognostic score in patients undergoing surgery for bone and soft tissue sarcoma.
Morhij R; Mahendra A; Jane M; McMillan DC
J Plast Reconstr Aesthet Surg; 2017 May; 70(5):618-624. PubMed ID: 28342782
[TBL] [Abstract][Full Text] [Related]
19. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.
Proctor MJ; Morrison DS; Talwar D; Balmer SM; Fletcher CD; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC
Eur J Cancer; 2011 Nov; 47(17):2633-41. PubMed ID: 21724383
[TBL] [Abstract][Full Text] [Related]
20. The Glasgow Microenvironment Score: an exemplar of contemporary biomarker evolution in colorectal cancer.
Knight K; Bigley C; Pennel K; Hay J; Maka N; McMillan D; Park J; Roxburgh C; Edwards J
J Pathol Clin Res; 2024 Jul; 10(4):e12385. PubMed ID: 38853386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]